Loading…
Sectoral / Thematic · SBI Mutual Fund · AMFI code 100644SBI Healthcare Opportunities Fund
Disclosed for 41 months, Jan 2023 to Sep 2026.
Portfolio value
₹1,843 Cr
up ₹138 Cr vs May 2023
- Stocks held
- 21
- up 1 vs May 2023
- Top 10 weight
- 70.8%
- of the portfolio in its ten largest
- Cash & debt
- 1.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 2
SBI Healthcare Opportunities Fund is an active equity fund in the Sectoral / Thematic category from SBI Mutual Fund. In June 2023 it disclosed 21 stocks worth ₹1,843 Cr, up ₹138 Cr from May 2023. Its largest positions were Sun Pharmaceutical Industries Limited (16.0%), Aether Industries Ltd. (8.1%), Cipla Limited (7.9%); the ten largest together made up 70.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 64.8% of its equity. Cash and debt stood at 1.5%. Compared with May 2023 the fund entered 1 new stock and exited 0.
Against 227 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
4%
Holds more stocks than 4% of peers
Cash
22%
Holds more cash than 22% of peers
Holdings in June 2023
Download CSVEvery line the fund disclosed, with the change against May 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 15.97%
- Δ weight
- up 0.53 pts
- Value
- ₹294 Cr
- Δ value
- up ₹31.1 Cr
- Status
- Added
- Weight
- 8.11%
- Δ weight
- up 1.77 pts
- Value
- ₹150 Cr
- Δ value
- up ₹41.4 Cr
- Status
- Added
- Weight
- 7.93%
- Δ weight
- down 0.34 pts
- Value
- ₹146 Cr
- Δ value
- up ₹5.1 Cr
- Status
- Added
- Weight
- 7.78%
- Δ weight
- down 0.30 pts
- Value
- ₹143 Cr
- Δ value
- up ₹5.6 Cr
- Status
- Added
- Weight
- 6.48%
- Δ weight
- up 0.90 pts
- Value
- ₹119 Cr
- Δ value
- up ₹24.3 Cr
- Status
- Added
- Weight
- 5.27%
- Δ weight
- up 0.14 pts
- Value
- ₹97.2 Cr
- Δ value
- up ₹9.6 Cr
- Status
- Added
- Weight
- 5.21%
- Δ weight
- down 0.59 pts
- Value
- ₹96.1 Cr
- Δ value
- down ₹2.8 Cr
- Status
- Trimmed
- Weight
- 5.20%
- Δ weight
- up 0.05 pts
- Value
- ₹95.9 Cr
- Δ value
- up ₹8 Cr
- Status
- Added
- Weight
- 5.01%
- Δ weight
- up 0.14 pts
- Value
- ₹92.3 Cr
- Δ value
- up ₹9.4 Cr
- Status
- Added
- Weight
- 3.81%
- Δ weight
- down 0.13 pts
- Value
- ₹70.3 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 3.56%
- Δ weight
- down 0.01 pts
- Value
- ₹65.6 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 3.46%
- Δ weight
- up 1.29 pts
- Value
- ₹63.8 Cr
- Δ value
- up ₹26.8 Cr
- Status
- Added
- Weight
- 3.42%
- Δ weight
- up 1.00 pts
- Value
- ₹63 Cr
- Δ value
- up ₹21.8 Cr
- Status
- Added
- Weight
- 3.10%
- Δ weight
- down 0.13 pts
- Value
- ₹57.1 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 3.09%
- Δ weight
- up 0.37 pts
- Value
- ₹56.9 Cr
- Δ value
- up ₹10.6 Cr
- Status
- Added
- Weight
- 2.59%
- Δ weight
- up 2.59 pts
- Value
- ₹47.8 Cr
- Δ value
- up ₹47.8 Cr
- Status
- New
- Weight
- 2.53%
- Δ weight
- up 0.17 pts
- Value
- ₹46.6 Cr
- Δ value
- up ₹6.5 Cr
- Status
- Added
- Weight
- 2.07%
- Δ weight
- down 0.07 pts
- Value
- ₹38.2 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.47%
- Δ weight
- down 6.33 pts
- Value
- ₹27.1 Cr
- Δ value
- down ₹106 Cr
- Status
- Trimmed
- Weight
- 1.27%
- Δ weight
- up 0.10 pts
- Value
- ₹23.4 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Weight
- 1.23%
- Δ weight
- down 1.16 pts
- Value
- ₹22.6 Cr
- Δ value
- down ₹18 Cr
- Status
- Trimmed
- Weight
- 1.08%
- Δ weight
- up 0.03 pts
- Value
- ₹19.9 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Shreno Ltd.Other
- Weight
- 0.37%
- Δ weight
- down 0.03 pts
- Value
- ₹6.7 Cr
- Δ value
- up ₹5 L
- Status
- Added
What changed, May 2023 to Jun 2023
New New positions (1)
- Biocon Limited2.6% · ₹47.8 Cr
Exited Exited (0)
None.
Added Biggest additions
- Aether Industries Ltd.up ₹41.4 Cr (+1.77% pts)
- Sun Pharmaceutical Industries Limitedup ₹31.1 Cr (+0.53% pts)
- Gland Pharma Limitedup ₹26.8 Cr (+1.29% pts)
- Mankind Pharma Limitedup ₹24.3 Cr (+0.90% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2023, the weight rose most in Chemicals & Petrochemicals (+1.4 pts) and Pharmaceuticals & Biotechnology (+0.9 pts), and fell most in Retailing (−1.3 pts) and Healthcare Services (−0.9 pts).
- Chemicals & Petrochemicals6.9% → 8.3%+1.4 pts
- Pharmaceuticals & Biotechnology63.9% → 64.8%+0.9 pts
- Retailing2.6% → 1.2%−1.3 pts
- Healthcare Services26.6% → 25.7%−0.9 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2023 | May 2023 | Jun 2023 |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 52.9% | 63.9% | 64.8% |
| Healthcare Services | 36.1% | 26.6% | 25.7% |
| Chemicals & Petrochemicals | 7.2% | 6.9% | 8.3% |
| Retailing | 3.8% | 2.6% | 1.2% |
Allocation in Jun 2023change vs May 2023
- Pharmaceuticals & Biotechnology (13)64.8%▲ 0.9 pts
- Healthcare Services (6)25.7%▼ 0.9 pts
- Chemicals & Petrochemicals (1)8.3%▲ 1.4 pts
- Retailing (1)1.2%▼ 1.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jun 2023
1.5%
▼ 6.3 pts vs May 2023
- Cash alone
- 1.5%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.7% – 7.8%
- lowest to highest · record 7.8% in May 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.